Clinical Study
Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C
Table 1
Baseline characteristics of the study population.
| ||||||||||||||||||||||||||||||
Available in 489 (81%) and 584 (97%) of patients. DM: diabetes mellitus; BMI: body mass index; RVR: rapid virological response; WBC: white cell count; N-L ratio: neutrophil-lymphocyte ratio. |